Our Mission

Mission Statement: Independent Aesthetic Practitioners (IAP)

• The latest data indicates that the UK’s beauty and personal care sector contributed £27.2 billion, approaching pre-COVID levels of £28 billion.
• IAPs operate within the private cosmetic sector and are fully tax-contributing professionals. As part of a thriving industry, we contribute significantly to the local and national economy through taxation, employment, supply chain and entrepreneurial activity.
• By remaining classified as a cosmetic industry, aesthetics continues to:
• Fund essential public services such as the NHS and education.
• Support employment and entrepreneurial growth.
• Keep high streets busy, sustain the supply chain, and promote local business development.

• Clients make informed decisions about consultation preferences, including remote prescribing.
• Informed consent remains a cornerstone for ethical, aesthetic practice.
• Remote prescribing is an established regulatory model consistent with frameworks used by NHS England in digital healthcare

• We advocate for a national, standardised qualification structure rooted in existing government education frameworks.
• Entry to injectable aesthetics should require a minimum of Beauty Therapy Level 3.
• Government-backed routes (VTCT and NVQ) already exist and are accessible, promoting vocational entry for young people.

• Mandatory CPD training covering complications management and advanced infection control is provided every two years.
• First aid training is taken and maintained according to existing government recommendations.
• Yearly reflective practice meetings to discuss practitioner wellbeing in the industry, licensing, regulatory concerns, and health and safety.
• The digital records system is aligned with NHS standards to ensure traceability and accountability.

• Treatments should take place  in clean, dedicated, infection-controlled environments.
• Practitioners must-have emergency supplies and the ability to initiate retrospective remote prescribing in emergencies (e.g., VO or vascular occlusion)
• Emergency protocols should align with Resuscitation Council UK guidlines.

• Botulinum toxin poses minimal risks.
• MHRA records show only 188 adverse events in 25 years, confirming a low-risk profile
• Regulation should be proportionate, evidence-led, and based on real-world outcomes, insurance coverage trends, and data.

• IAPs support ethical, inclusive practice.
• Membership is limited to non-surgical, non-permanent aesthetic procedures.
• Annual topics such as mental awareness ensure we remain mindful of the client’s well-being.
• Standardised consent processes and clear boundaries promote accessibility without discrimination. 
• DBS checks are not required as we provide elective cosmetic treatments to consenting adults, and it would be impossible to define where such checks should begin or end. 

• Training providers should operate within a fair, transparent pricing structure and maintain consistent educational standards.
• A public register of IAPs will help clients verify training and qualifications.
• Further clinical oversight is unnecessary, provided these guidelines are adhered to.